1.Li G, Ma J, Cui S, He Y, Xiao Q, Liu J, et al. Parkinson’s disease in China: a forty-year growing track of bedside work. Transl Neurodegener. 2019;8:22. Epub 2019/08/07. doi: 10.1186/s40035–019–0162-z. PubMed PMID: 31384434; PubMed Central PMCID: PMCPMC6668186.
2.Wang C, Cai Y, Gu Z, Ma J, Zheng Z, Tang BS, et al. Clinical profiles of Parkinson’s disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals. Neurobiol Aging. 2014;35(3):725 e1–6. Epub 2013/10/08. doi: 10.1016/j.neurobiolaging.2013.08.012. PubMed PMID: 24095219.
3.Peeraully T, Tan EK. Genetic variants in Sporadic Parkinson’s Disease: East vs West. Parkinsonism & Related Disorders. 2012;18:S63-S5. doi: 10.1016/s1353–8020(11)70021–9.
4.Oosterveld LP AJJ, Ng EY, Seah SH, Tay KY, Au WL, Tan EK, Tan LC. Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants. Neurology. 2015;85(12):1039–42.
5.Wu YR, Chang KH, Chang WT, Hsiao YC, Hsu HC, Jiang PR, et al. Genetic variants ofLRRK2 in Taiwanese Parkinson’s disease. PLoS One. 2013;8(12):e82001. Epub 2013/12/18. doi: 10.1371/journal.pone.0082001. PubMed PMID: 24339985; PubMed Central PMCID: PMCPMC3855417.
6.Xiao B DX, Ng EY, Allen JC Jr, Lim SY, Ahmad-Annuar A, Tan EK. Association of LRRK2 Haplotype With Age at Onset in Parkinson Disease. JAMA Neurol. 2018;75(1):127–8.
7.Sun Q, Wang T, Jiang TF, Huang P, Li DH, Wang Y, et al. Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson’s Disease Patients. Aging Dis. 2016;7(3):230–6. Epub 2016/06/23. doi: 10.14336/AD.2015.1026. PubMed PMID: 27330837; PubMed Central PMCID: PMCPMC4898919.
8.Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–601. Epub 2015/10/17. doi: 10.1002/mds.26424. PubMed PMID: 26474316.
9.Chen W KW, Chen S, Wang Y, Xiao Q, Wang G, Liu J, Chen SD. Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(6):610–4.
10.Shen SS, Shen Y, Xiong KP, Chen J, Mao CJ, Huang JY, et al. Validation study of REM sleep behavior disorder questionnaire-Hong Kong (RBDQ-HK) in east China. Sleep Med. 2014;15(8):952–8. Epub 2014/06/19. doi: 10.1016/j.sleep.2014.03.020. PubMed PMID: 24938584.
11.Ahmad NN C-UA, Donoso LA. Modification of standard proteinase K:phenol method for DNA isolation to improve yield and purity from frozen blood. J Med Genet 1995;32(2):129–30.
12.Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, et al. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat. 2010;31(5):561–8. Epub 2010/02/27. doi: 10.1002/humu.21225. PubMed PMID: 20186690.
13.Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF, et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan. Neurogenetics. 2006;7(3):133–8. Epub 2006/04/25. doi: 10.1007/s10048–006–0041–5. PubMed PMID: 16633828.
14.Wang C, Cai Y, Zheng Z, Tang BS, Xu Y, Wang T, et al. Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Parkinsonism Relat Disord. 2012;18(8):958–63. Epub 2012/06/05. doi: 10.1016/j.parkreldis.2012.05.003. PubMed PMID: 22658533.
15.Cilia R, Siri C, Rusconi D, Allegra R, Ghiglietti A, Sacilotto G, et al. LRRK2 mutations in Parkinson’s disease: confirmation of a gender effect in the Italian population. Parkinsonism Relat Disord. 2014;20(8):911–4. Epub 2014/05/13. doi: 10.1016/j.parkreldis.2014.04.016. PubMed PMID: 24816003; PubMed Central PMCID: PMCPMC4144811.
16.Hao M PN, Zhang Q, Wang X Mutant of leucine-rich repeat kinase 2 is not associated with non- motor symptoms in Chinese Parkinson’s disease patients.. Int J Clin Exp Med. 2014;7:2253–7.
17.Zheng Y, Liu Y, Wu Q, Hong H, Zhou H, Chen J, et al. Confirmation of LRRK2 S1647T variant as a risk factor for Parkinson’s disease in southern China. Eur J Neurol. 2011;18(3):538–40. Epub 2010/07/16. doi: 10.1111/j.1468–1331.2010.03164.x. PubMed PMID: 20629711.
18.Lin CH, Wu RM, Tai CH, Chen ML, Hu FC. Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(2):84–8. Epub 2010/12/21. doi: 10.1016/j.parkreldis.2010.11.011. PubMed PMID: 21167764.
19.Zheng Y, Pei Z, Liu Y, Zhou H, Xian W, Fang Y, et al. Cognitive Impairments in LRRK2-Related Parkinson’s Disease: A Study in Chinese Individuals. Behavioural Neurology. 2015;2015:1–5. doi: 10.1155/2015/621873.
20.Ouled Amar Bencheikh B, Ruskey JA, Arnulf I, Dauvilliers Y, Monaca CC, De Cock VC, et al. LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder. Parkinsonism & Related Disorders. 2018;52:98–101. doi: 10.1016/j.parkreldis.2018.03.019.